Copyright Reports & Markets. All rights reserved.

Global Sickle Cell Disease Treatment Market Research Report 2019

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Sickle Cell Disease Treatment Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Sickle Cell Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Sickle Cell Anemia
    • 1.4.3 Sickle Beta Thalassemia
    • 1.4.4 Sickle Hemoglobin C Disease
  • 1.5 Market by Application
    • 1.5.1 Global Sickle Cell Disease Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Sickle Cell Disease Treatment Market Perspective (2015-2026)
  • 2.2 Global Sickle Cell Disease Treatment Growth Trends by Regions
    • 2.2.1 Sickle Cell Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Sickle Cell Disease Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Sickle Cell Disease Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Sickle Cell Disease Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Sickle Cell Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Sickle Cell Disease Treatment Players by Market Size
    • 3.1.1 Global Top Sickle Cell Disease Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Sickle Cell Disease Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Sickle Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Sickle Cell Disease Treatment Market Concentration Ratio
    • 3.2.1 Global Sickle Cell Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatment Revenue in 2019
  • 3.3 Sickle Cell Disease Treatment Key Players Head office and Area Served
  • 3.4 Key Players Sickle Cell Disease Treatment Product Solution and Service
  • 3.5 Date of Enter into Sickle Cell Disease Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Sickle Cell Disease Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Sickle Cell Disease Treatment Market Size by Application (2015-2020)
  • 5.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Sickle Cell Disease Treatment Market Size (2015-2020)
  • 6.2 Sickle Cell Disease Treatment Key Players in North America (2019-2020)
  • 6.3 North America Sickle Cell Disease Treatment Market Size by Type (2015-2020)
  • 6.4 North America Sickle Cell Disease Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Sickle Cell Disease Treatment Market Size (2015-2020)
  • 7.2 Sickle Cell Disease Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Sickle Cell Disease Treatment Market Size by Type (2015-2020)
  • 7.4 Europe Sickle Cell Disease Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China Sickle Cell Disease Treatment Market Size (2015-2020)
  • 8.2 Sickle Cell Disease Treatment Key Players in China (2019-2020)
  • 8.3 China Sickle Cell Disease Treatment Market Size by Type (2015-2020)
  • 8.4 China Sickle Cell Disease Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Sickle Cell Disease Treatment Market Size (2015-2020)
  • 9.2 Sickle Cell Disease Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Sickle Cell Disease Treatment Market Size by Type (2015-2020)
  • 9.4 Japan Sickle Cell Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Sickle Cell Disease Treatment Market Size (2015-2020)
  • 10.2 Sickle Cell Disease Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Sickle Cell Disease Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Sickle Cell Disease Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Sickle Cell Disease Treatment Market Size (2015-2020)
  • 11.2 Sickle Cell Disease Treatment Key Players in India (2019-2020)
  • 11.3 India Sickle Cell Disease Treatment Market Size by Type (2015-2020)
  • 11.4 India Sickle Cell Disease Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Sickle Cell Disease Treatment Market Size (2015-2020)
  • 12.2 Sickle Cell Disease Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Sickle Cell Disease Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Sickle Cell Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 AstraZeneca
    • 13.1.1 AstraZeneca Company Details
    • 13.1.2 AstraZeneca Business Overview
    • 13.1.3 AstraZeneca Sickle Cell Disease Treatment Introduction
    • 13.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2015-2020))
    • 13.1.5 AstraZeneca Recent Development
  • 13.2 Eli Lilly
    • 13.2.1 Eli Lilly Company Details
    • 13.2.2 Eli Lilly Business Overview
    • 13.2.3 Eli Lilly Sickle Cell Disease Treatment Introduction
    • 13.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 13.2.5 Eli Lilly Recent Development
  • 13.3 Novartis
    • 13.3.1 Novartis Company Details
    • 13.3.2 Novartis Business Overview
    • 13.3.3 Novartis Sickle Cell Disease Treatment Introduction
    • 13.3.4 Novartis Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 13.3.5 Novartis Recent Development
  • 13.4 Pfizer
    • 13.4.1 Pfizer Company Details
    • 13.4.2 Pfizer Business Overview
    • 13.4.3 Pfizer Sickle Cell Disease Treatment Introduction
    • 13.4.4 Pfizer Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 13.4.5 Pfizer Recent Development
  • 13.5 Baxter
    • 13.5.1 Baxter Company Details
    • 13.5.2 Baxter Business Overview
    • 13.5.3 Baxter Sickle Cell Disease Treatment Introduction
    • 13.5.4 Baxter Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 13.5.5 Baxter Recent Development
  • 13.6 Emmaus Life Sciences
    • 13.6.1 Emmaus Life Sciences Company Details
    • 13.6.2 Emmaus Life Sciences Business Overview
    • 13.6.3 Emmaus Life Sciences Sickle Cell Disease Treatment Introduction
    • 13.6.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 13.6.5 Emmaus Life Sciences Recent Development
  • 13.7 Bluebird bio
    • 13.7.1 Bluebird bio Company Details
    • 13.7.2 Bluebird bio Business Overview
    • 13.7.3 Bluebird bio Sickle Cell Disease Treatment Introduction
    • 13.7.4 Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 13.7.5 Bluebird bio Recent Development
  • 13.8 Blood Therapeutics
    • 13.8.1 Blood Therapeutics Company Details
    • 13.8.2 Blood Therapeutics Business Overview
    • 13.8.3 Blood Therapeutics Sickle Cell Disease Treatment Introduction
    • 13.8.4 Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 13.8.5 Blood Therapeutics Recent Development
  • 13.9 Sangamo Therapeutics
    • 13.9.1 Sangamo Therapeutics Company Details
    • 13.9.2 Sangamo Therapeutics Business Overview
    • 13.9.3 Sangamo Therapeutics Sickle Cell Disease Treatment Introduction
    • 13.9.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 13.9.5 Sangamo Therapeutics Recent Development
  • 13.10 Acceleron Pharma
    • 13.10.1 Acceleron Pharma Company Details
    • 13.10.2 Acceleron Pharma Business Overview
    • 13.10.3 Acceleron Pharma Sickle Cell Disease Treatment Introduction
    • 13.10.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 13.10.5 Acceleron Pharma Recent Development
  • 13.11 Arena Pharmaceuticals
    • 10.11.1 Arena Pharmaceuticals Company Details
    • 10.11.2 Arena Pharmaceuticals Business Overview
    • 10.11.3 Arena Pharmaceuticals Sickle Cell Disease Treatment Introduction
    • 10.11.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 10.11.5 Arena Pharmaceuticals Recent Development
  • 13.12 Alnylam Pharmaceuticals
    • 10.12.1 Alnylam Pharmaceuticals Company Details
    • 10.12.2 Alnylam Pharmaceuticals Business Overview
    • 10.12.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Introduction
    • 10.12.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2015-2020)
    • 10.12.5 Alnylam Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Sickle Cell Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sickle Cell Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    AstraZeneca
    Eli Lilly
    Novartis
    Pfizer
    Baxter
    Emmaus Life Sciences
    Bluebird bio
    Blood Therapeutics
    Sangamo Therapeutics
    Acceleron Pharma
    Arena Pharmaceuticals
    Alnylam Pharmaceuticals

    Market segment by Type, the product can be split into
    Sickle Cell Anemia
    Sickle Beta Thalassemia
    Sickle Hemoglobin C Disease
    Market segment by Application, split into
    Hospitals
    Clinics
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now